Literature DB >> 21050173

Mitragyna speciosa, a psychoactive tree from Southeast Asia with opioid activity.

Jessica E Adkins1, Edward W Boyer, Christopher R McCurdy.   

Abstract

Mitragyna speciosa Korth. (Rubiaceae) is a tree that is commonly found in Southeast Asia. Leaves from this tree have been traditionally been used for both their stimulant properties as well as an opium substitute. The tree/leaves are currently illegal in four countries, but is currently legal and widely available in the United States. To date over 40 compounds have been isolated from the leaves. The major alkaloid found within the crude extract, mitragynine, has been the subject of many pharmacological studies. In addition to the pharmacological studies, two total syntheses of mitragynine have been published as well as general structure-activity relationships (SARs) with respect to opioid activity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21050173     DOI: 10.2174/156802611795371305

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  42 in total

Review 1.  Herbal medicines for the management of opioid addiction: safe and effective alternatives to conventional pharmacotherapy?

Authors:  Jeanine Ward; Christopher Rosenbaum; Christina Hernon; Christopher R McCurdy; Edward W Boyer
Journal:  CNS Drugs       Date:  2011-12-01       Impact factor: 5.749

Review 2.  Here today, gone tomorrow…and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines.

Authors:  Christopher D Rosenbaum; Stephanie P Carreiro; Kavita M Babu
Journal:  J Med Toxicol       Date:  2012-03

3.  The Right to Use Kratom from the Psychiatric and Islamic Perspectives.

Authors:  Mohammad Farris Iman Leong Bin Abdullah; Mohd Afifuddin Mohamad; Noor Naemah Abdul Rahman
Journal:  J Relig Health       Date:  2021-04

4.  Plants with Anti-Addictive Potential.

Authors:  Eduardo Luis Konrath; Marcelo Dutra Arbo; Bruno Dutra Arbo; Mariana Appel Hort; Elaine Elisabetsky; Mirna Bainy Leal
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Mitragyna speciosa: Balancing Potential Medical Benefits and Abuse.

Authors:  Genevieve M Halpenny
Journal:  ACS Med Chem Lett       Date:  2017-08-08       Impact factor: 4.345

6.  The inhibitory effects of mitragynine on P-glycoprotein in vitro.

Authors:  Noradliyanti Rusli; Azimah Amanah; Gurjeet Kaur; Mohd Ilham Adenan; Shaida Fariza Sulaiman; Habibah Abdul Wahab; Mei Lan Tan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-01-02       Impact factor: 3.000

7.  Pentylenetetrazol-like stimulus is not produced following naloxone-precipitated mitragynine withdrawal in rats.

Authors:  Illa S Johari; Norsyifa Harun; Zarif M Sofian; Mohammed Shoaib
Journal:  Psychopharmacology (Berl)       Date:  2021-08-01       Impact factor: 4.530

8.  Synthetic and Receptor Signaling Explorations of the Mitragyna Alkaloids: Mitragynine as an Atypical Molecular Framework for Opioid Receptor Modulators.

Authors:  Andrew C Kruegel; Madalee M Gassaway; Abhijeet Kapoor; András Váradi; Susruta Majumdar; Marta Filizola; Jonathan A Javitch; Dalibor Sames
Journal:  J Am Chem Soc       Date:  2016-05-18       Impact factor: 15.419

9.  Pharmacokinetics and Safety of Mitragynine in Beagle Dogs.

Authors:  Elizabeth A Maxwell; Tamara I King; Shyam H Kamble; Kanumuri Siva Rama Raju; Erin C Berthold; Francisco León; Bonnie A Avery; Lance R McMahon; Christopher R McCurdy; Abhisheak Sharma
Journal:  Planta Med       Date:  2020-07-21       Impact factor: 3.352

10.  Development and validation of a UPLC-MS/MS method for the determination of 7-hydroxymitragynine, a μ-opioid agonist, in rat plasma and its application to a pharmacokinetic study.

Authors:  Pradeep K Vuppala; Seshulatha Jamalapuram; Edward B Furr; Christopher R McCurdy; Bonnie A Avery
Journal:  Biomed Chromatogr       Date:  2013-07-25       Impact factor: 1.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.